EQL Pharma AB (FRA:7JK) Other Long-Term Liabilities : €1.55 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is EQL Pharma AB Other Long-Term Liabilities?

EQL Pharma AB's other long-term liabilities for the quarter that ended in Mar. 2024 was €1.55 Mil.

EQL Pharma AB's quarterly other long-term liabilities increased from Sep. 2023 (€1.27 Mil) to Dec. 2023 (€1.49 Mil) and increased from Dec. 2023 (€1.49 Mil) to Mar. 2024 (€1.55 Mil).

EQL Pharma AB's annual other long-term liabilities increased from Mar. 2022 (€0.39 Mil) to Mar. 2023 (€1.07 Mil) and increased from Mar. 2023 (€1.07 Mil) to Mar. 2024 (€1.55 Mil).

EQL Pharma AB Other Long-Term Liabilities Historical Data

The historical data trend for EQL Pharma AB's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EQL Pharma AB Other Long-Term Liabilities Chart

EQL Pharma AB Annual Data

Trend

Dec14

Dec15

Dec16

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Other Long-Term Liabilities

Get a 7-Day Free Trial

EQL Pharma AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

EQL Pharma AB Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

EQL Pharma AB Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of EQL Pharma AB's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

EQL Pharma AB (FRA:7JK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EQL Pharma AB (FRA:7JK) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

EQL:Sweden

Address

Stortorget 1, 3rd Floor, Lund, SWE, 222 23

Website

http://www.eqlpharma.com

EQL Pharma AB is a pharmaceutical company engaged in developing and selling medicines to pharmacies and hospitals. The products offered by the company include generics and parallel imports. It operates and markets products to Nordic countries of Sweden, Denmark, Finland and Norway.

EQL Pharma AB (FRA:7JK) Headlines

No Headlines